结核性脓胸198例的外科治疗

随着结核病发病率明显回升,结核性脓胸的病例也明显增多.结核性脓胸的病程长,手术治疗的难度大且并发症较多.1995年1月至2008年1月北京胸科医院采用不同外科手术方式治疗198例结核性脓胸,效果良好,现将结果报道如下.     

非小细胞肺癌循环肿瘤细胞的定量检测意义

Objective To investigate the sensitivity, specificity and clinical significance of detecting circulating tomor cells (CTCs) in NSCLC. Methods Twenty-five patients who undetwent surgical resection for NSCLC form Jan 2007 to Apr 2007 were in- cluded in this study. Control group included 10 patients with benign pulmonary diseses (2 case of hamartoma and 8 case of pulmonary tu berculosis) and 10 healthy volunteers. The pulmonary veins blood and peripheral vein blood were collected respectively. The CD326 immunomagnetic beads and CK-fluorescein isothiocyanate (CK-FITC) were served as the marker antibodies of CTCs. Firstly mononu- clear cell marked by minibeads conjugated with CD326, the mononuclear cells were enriched and separated though Magnetic-activated cell separation(MACS), then the positive separtion cells were marked by anti-CK-FTTC and anti-leukocyte antibody CD45-phyco- erythrine (anti-CD45-PE), finally those cells detected and analyzed by flow cytometry . Results For stage Ⅰ and stage Ⅱ patients (n= 16), CTCs were detected from peripheral vein blood of in 5 (5/16, 31.25%) and from pulmonary veins blood in 9 (9/16, 56.25%). For stage Ⅲ and stage Ⅳ, CTCs were detected from peripheral vein blood in 5 (5/9, 55.56%) and from pulmonary veins blood in 9(7/9,77.78%).For stage Ⅰ,CTCs were detected from peripheral vein blood in 3(3/13,23%)and from pulmo- nery veins blood in 8(8/13,61.54%).The whole CTCs positive detection rate from pilmonary veins blood was 64%(16/25)which higher than feom peripheral vein blood(40%,10/25)(P<0.05).Conclusion The method was set up by MACS combined with FCM to detect the CTCs of pulmonary veins blood and peripheral vein blood of patients.with NSCLC,MACS combined with FCM may improve detection rate of CTCs.This technique appears to be an efficient to detect circulating tumor cells and may be important for dinical practice in the future.     

21例肺曲菌病误诊为肺结核的原因分析

目的 提高肺曲菌病与肺结核病的鉴别水平，提高对肺曲菌病的认识。方法 对2l例经手术病理证实为肺曲菌病曾误诊为肺结核病的原因进行回顾性分析。结果 本组病例平均年龄35．9岁，平均病程31．9个月，主要症状为咳嗽、咳痰、咯血、发热、胸痛、胸闷、乏力、盗汗、消瘦。X线有典型“新月征”表现为9例，余X线表现不典型。所有病例痰结核菌检查均阴性，经正规抗结核及抗生素治疗，其中2例抗真菌治疗，病情变化不明显。结论 造成误诊原因主要是肺曲菌病与肺结核病二者临床表现及X线表现的相似。痰曲菌检查阳性率低，胸片有“新月征”表现者应想到肺曲菌病。     

以重度肌无力综合征为首发表现的肺癌误诊防范

以肺外表现为首发症状的肺癌 ,往往首发症状掩盖了原发病 ,这类患者占肺癌总例数 3 8 6% [1] ,以肌无力综合征为首发表现的肺癌约占此类患者 7 5% [3] 。这种肺外表现多出现在呼吸道症状前 ,极易被忽视。肺癌的非转移性肺外表现非常复杂多样 ,本文从 80 0例完整肺癌资料中整理出 1 8例以重度肌无力综合征为首发症状的病例 ,现分析报道如下。1　临床资料以重度肌无力为首发症状的肺癌占同期收治肺癌病例的 2 2 5% ( 1 8/ 80 0 ) ,其中男性 1 2例 ,女性 6例 ,年龄 2 2～ 70岁 ,其病理类型不一 (见表 1 )。表 1　以重度肌无力为首发症状的肺癌…     

支气管镜在肺外科的应用价值

支气管镜在肺外科的应用价值林美云，张毅，李福根，王丽华，李淑兰北京结核病、胸部肿瘤研究所（北京１０１１４９）肺癌是危害人民健康的恶性肿瘤，近年来其死亡率正逐年上升。因而，在第五届世界肺癌会议上，它已同艾滋病并列，被与会专家们宣称是“２１世纪初期最常见...     

新型引流装置在胸腹腔积液患者中的应用

<正>胸腹腔积液一般是由恶性肿瘤或者癌症引起的浆膜腔液体的异常聚集,形成的速度快,液体量较大[1],是肿瘤患者晚期的表现之一,主要的症状是腹胀、呼吸困难、胸闷、气短、恶心等,严重影响患者的生活质量,控制胸腹腔积液的产生速度或者清除积液对于患者的治疗及预后至关重要,临床上应用引流技术清除患者胸腹腔积液,但是不同的引流装置效果明显不同,本研究对我院收治的胸腹腔积液患者使用新型装置进行引流,效果良好,现报道如下。     

氟尿嘧啶 甲氰咪胍治疗急性胰腺炎的疗效观察

我们在临床上采用氟尿嘧啶(5-FU) 甲氰咪胍(CMT)治疗急性水肿型胰腺炎10例,并与常规传统疗法(10例)进行对照,现将结果报告如下。临床资料1.观察对象:急性水肿型胰腺炎20例,全部有恶心、上腹持续性疼痛及压痛症状体征。治疗组7例,对照组8例伴有呕吐胃内容物。入院24小时内检     

非小细胞肺癌循环肿瘤细胞的定量检测意义

目的 探讨定量检测非小细胞肺癌病人肺静脉和外周静脉血循环肿瘤细胞与临床分期、治疗及预后监测的相关性.方法 选择25例非小细胞肺癌病人,10例良性肺疾病者(对照组)、健康志愿者10位.经CD326免疫磁珠阳性分选富集循环肿瘤细胞(CTCs)标本后,行CK-FITC、CD45PE荧光抗体标记,应用多参数流式细胞仪对CTCs进行定量检测.结果 25例非小细胞肺癌病人术中肺静脉血CTCs定量检测阳性率为64%(16/25例),明显高于外周静脉血CTCs阳性率40%(10/25例)的水平(P<0.05);Ⅰ期13例中外周血CTCs阳性3例(23.0%),肺静脉血CTCs阳性8例(61.5%).结论 非小细胞肺癌CTCs水平的定量检测是较为敏感的肿瘤进展、治疗反应和预后预测的评价指标;免疫磁珠富集联合流式细胞分析技术检测CTCs的敏感性和特异性较高,具有一定的临床应用前景.     

非小细胞肺癌循环肿瘤细胞的定量检测意义

Objective To investigate the sensitivity, specificity and clinical significance of detecting circulating tomor cells (CTCs) in NSCLC. Methods Twenty-five patients who undetwent surgical resection for NSCLC form Jan 2007 to Apr 2007 were in- cluded in this study. Control group included 10 patients with benign pulmonary diseses (2 case of hamartoma and 8 case of pulmonary tu berculosis) and 10 healthy volunteers. The pulmonary veins blood and peripheral vein blood were collected respectively. The CD326 immunomagnetic beads and CK-fluorescein isothiocyanate (CK-FITC) were served as the marker antibodies of CTCs. Firstly mononu- clear cell marked by minibeads conjugated with CD326, the mononuclear cells were enriched and separated though Magnetic-activated cell separation(MACS), then the positive separtion cells were marked by anti-CK-FTTC and anti-leukocyte antibody CD45-phyco- erythrine (anti-CD45-PE), finally those cells detected and analyzed by flow cytometry . Results For stage Ⅰ and stage Ⅱ patients (n= 16), CTCs were detected from peripheral vein blood of in 5 (5/16, 31.25%) and from pulmonary veins blood in 9 (9/16, 56.25%). For stage Ⅲ and stage Ⅳ, CTCs were detected from peripheral vein blood in 5 (5/9, 55.56%) and from pulmonary veins blood in 9(7/9,77.78%).For stage Ⅰ,CTCs were detected from peripheral vein blood in 3(3/13,23%)and from pulmo- nery veins blood in 8(8/13,61.54%).The whole CTCs positive detection rate from pilmonary veins blood was 64%(16/25)which higher than feom peripheral vein blood(40%,10/25)(P<0.05).Conclusion The method was set up by MACS combined with FCM to detect the CTCs of pulmonary veins blood and peripheral vein blood of patients.with NSCLC,MACS combined with FCM may improve detection rate of CTCs.This technique appears to be an efficient to detect circulating tumor cells and may be important for dinical practice in the future.     

非小细胞肺癌循环肿瘤细胞的定量检测意义

Objective To investigate the sensitivity, specificity and clinical significance of detecting circulating tomor cells (CTCs) in NSCLC. Methods Twenty-five patients who undetwent surgical resection for NSCLC form Jan 2007 to Apr 2007 were in- cluded in this study. Control group included 10 patients with benign pulmonary diseses (2 case of hamartoma and 8 case of pulmonary tu berculosis) and 10 healthy volunteers. The pulmonary veins blood and peripheral vein blood were collected respectively. The CD326 immunomagnetic beads and CK-fluorescein isothiocyanate (CK-FITC) were served as the marker antibodies of CTCs. Firstly mononu- clear cell marked by minibeads conjugated with CD326, the mononuclear cells were enriched and separated though Magnetic-activated cell separation(MACS), then the positive separtion cells were marked by anti-CK-FTTC and anti-leukocyte antibody CD45-phyco- erythrine (anti-CD45-PE), finally those cells detected and analyzed by flow cytometry . Results For stage Ⅰ and stage Ⅱ patients (n= 16), CTCs were detected from peripheral vein blood of in 5 (5/16, 31.25%) and from pulmonary veins blood in 9 (9/16, 56.25%). For stage Ⅲ and stage Ⅳ, CTCs were detected from peripheral vein blood in 5 (5/9, 55.56%) and from pulmonary veins blood in 9(7/9,77.78%).For stage Ⅰ,CTCs were detected from peripheral vein blood in 3(3/13,23%)and from pulmo- nery veins blood in 8(8/13,61.54%).The whole CTCs positive detection rate from pilmonary veins blood was 64%(16/25)which higher than feom peripheral vein blood(40%,10/25)(P<0.05).Conclusion The method was set up by MACS combined with FCM to detect the CTCs of pulmonary veins blood and peripheral vein blood of patients.with NSCLC,MACS combined with FCM may improve detection rate of CTCs.This technique appears to be an efficient to detect circulating tumor cells and may be important for dinical practice in the future.